Assessing Market Opportunities in Contract Biologics Manufacturing
Strong growth in biopharmaceuticals bodes well for contract manufacturing, but the perils and the promises of pipelines remain.
Limits to Growth?
A major CRO ventures further into proprietary drug development.
Biotechnology in 2009
The president of BIO proposes the ingredients needed for industry growth.
Missing Something?
Process steps, GMP documents, a purification vessel, and validation seem to disappear.
Initial Solvent Screening of Carbamazepine, Cimetidine, and Phenylbutazone: Part 1 of 2
The authors describe the importance of a rapid and an abbreviated screening strategy by initial solvent screening in 20-mL scintillation vials.
Report From: Japan
The Japanese government is eager to jumpstart its generic-drug market, but changes must come first.
Taiwan Seeks to Strengthen its Intellectual Property Governance
Taiwan sees to bring its intellectual property laws and enforcment into better alignment with international standards.
Ethyl Lactate as a Pharmaceutical-Grade Excipient and Development of a Sensitive Peroxide Assay
The authors investigate whether the addition of an antioxidant could be used to stabilize the solvent ethyl lactate by preventing the formation of peroxides
Inside IPEC: Good Distribution Practices for Pharmaceutical Excipients
The GDP committee of IPEC–Europe is trying to seal one more broken link in the supply chain. This article contains bonus online-exclusive material.
Pharma Capsules
Brief pharmaceutical news items for May 2009.
Taiwan, No Longer a Life-Sciences Island Unto Itself
Taking a cue from its electronics industry, Taiwan is seeking to put its biotechnology and pharmaceutical industries on the map. An interactive map shows pharmaceutical activity in Taiwan.
The Comparative-Effectiveness Controversy
Government funding is slated to boost comparative studies of prescription drugs.
Easing the Bottleneck
Manufacturers of therapeutic monoclonal antibodies consider new paradigms in purification technologies.
To Protect and Package
Products at INTERPHEX focused on protection, compliance, and deterring counterfeiting. This article contains bonus online-exclusive material.
Industry Leaders Debate Follow-on Biologics Pathway
The organizations' presidents discuss market exclusivity, approval processes, and pending legislation.
Shop Floor and Top Floor, Unite!
Technology can solve enterprise-level problems.
In the Spotlight May 2009
Editors' Picks of Pharmaceutical Science & Technology Innovations
